Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis-Reference-Cited by-同舟云学术

Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis

Published:2021-11-23 Issue:20 Volume:326 Page:2031
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Aminian Ali¹,Al-Kurd Abbas¹,Wilson Rickesha¹,Bena James²,Fayazzadeh Hana¹,Singh Tavankit³⁴,Albaugh Vance L.¹⁵,Shariff Faiz U.¹⁶,Rodriguez Noe A.¹⁷,Jin Jian²,Brethauer Stacy A.¹⁸,Dasarathy Srinivasan³,Alkhouri Naim³⁹,Schauer Philip R.¹⁵,McCullough Arthur J.³,Nissen Steven E.¹⁰

Affiliation:

1. Bariatric and Metabolic Institute, Department of General Surgery, Cleveland Clinic, Cleveland, Ohio

2. Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio

3. Division of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio

4. Department of Gastroenterology and Hepatology, Allegheny General Hospital, Pittsburgh, Pennsylvania

5. Bariatric and Metabolic Institute, Pennington Biomedical Research Center, Baton Rouge, Louisiana

6. Department of Surgery, Wellspan Hospital, York, Pennsylvania

7. Department of Surgery, Northwest Medical Center, Springdale, Arkansas

8. Department of Surgery, Wexner Medical Center, Ohio State University, Columbus

9. Fatty Liver Program, Arizona Liver Health, Chandler

10. Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2786270/jama_aminian_2021_oi_210121_1637351911.70804.pdf

Reference32 articles.

1. Non-alcoholic fatty liver disease.;Powell;Lancet,2021

2. Nonalcoholic steatohepatitis: a review.;Sheka;JAMA,2020

3. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis.;Diehl;N Engl J Med,2017

4. Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus.;Ferguson;Nat Rev Endocrinol,2021

5. Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review.;Stahl;J Am Coll Cardiol,2019

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural history and progression of metabolic dysfunction-associated steatotic liver disease;The Lancet Gastroenterology & Hepatology;2024-10

2. Obesity Conundrum;The American Journal of Cardiology;2024-10

3. Long‐term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction‐associated fatty liver disease in adults with obesity and type 2 diabetes;Diabetes, Obesity and Metabolism;2024-09-12

4. Clinical Outcomes of Metabolic Surgery on Diuretic Use in Patients With Heart Failure;The American Journal of Cardiology;2024-09

5. Nonalcoholic fatty liver disease is a risk factor for cardiovascular disease;SCIENTIA SINICA Vitae;2024-09-01